SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-136290
Filing Date
2020-12-16
Accepted
2020-12-16 16:16:10
Documents
15
Period of Report
2020-12-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2038515d1_8k.htm   iXBRL 8-K 33741
2 EXHIBIT 1.1 tm2038515d1_ex1-1.htm EX-1.1 230945
3 EXHIBIT 5.1 tm2038515d1_ex5-1.htm EX-5.1 14827
7 GRAPHIC logo_001.jpg GRAPHIC 3079
  Complete submission text file 0001104659-20-136290.txt   518070

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20201214.xsd EX-101.SCH 3205
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20201214_lab.xml EX-101.LAB 34592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20201214_pre.xml EX-101.PRE 22723
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2038515d1_8k_htm.xml XML 3474
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 201392610
SIC: 2834 Pharmaceutical Preparations